EGAS00001001614-sc-20160629 - samples

ABSTRACT: This study involves mutagenizing C32, a melanoma cell line, with ENU to identify those mutations which engender resistance to a targeted treatment.

PROVIDER: EGAD00001002234 | EGA |

REPOSITORIES: EGA